Cargando…
Iron Rim Lesions as a Specific and Prognostic Biomarker of Multiple Sclerosis: 3T-Based Susceptibility-Weighted Imaging
This study aimed to identify the clinical significance of iron rim lesions (IRLs) in distinguishing multiple sclerosis (MS) from other central nervous system (CNS) demyelinating diseases, determine the relationship between IRLs and disease severity, and understand the long-term dynamic changes in IR...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252973/ https://www.ncbi.nlm.nih.gov/pubmed/37296717 http://dx.doi.org/10.3390/diagnostics13111866 |
_version_ | 1785056297769500672 |
---|---|
author | Kim, Sooyoung Lee, Eun Kyoung Song, Chang June Sohn, Eunhee |
author_facet | Kim, Sooyoung Lee, Eun Kyoung Song, Chang June Sohn, Eunhee |
author_sort | Kim, Sooyoung |
collection | PubMed |
description | This study aimed to identify the clinical significance of iron rim lesions (IRLs) in distinguishing multiple sclerosis (MS) from other central nervous system (CNS) demyelinating diseases, determine the relationship between IRLs and disease severity, and understand the long-term dynamic changes in IRLs in MS. We retrospectively evaluated 76 patients with CNS demyelinating diseases. CNS demyelinating diseases were classified into three groups: MS (n = 30), neuromyelitis optica spectrum disorder (n = 23), and other CNS demyelinating diseases (n = 23). MRI images were obtained using conventional 3T MRI including susceptibility-weighted imaging. Sixteen of 76 patients (21.1%) had IRLs. Of the 16 patients with IRLs, 14 were in the MS group (87.5%), indicating that IRLs were significantly specific for MS. In the MS group, patients with IRLs had a significantly higher number of total WMLs, experienced more frequent recurrence, and were treated more with second-line immunosuppressive agents than were patients without IRLs. In addition to IRLs, T1-blackhole lesions were observed more frequently in the MS group than in the other groups. IRLs are specific for MS and could represent a reliable imaging biomarker to improve the diagnosis of MS. Additionally, the presence of IRLs seems to reflect more severe disease progression in MS. |
format | Online Article Text |
id | pubmed-10252973 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102529732023-06-10 Iron Rim Lesions as a Specific and Prognostic Biomarker of Multiple Sclerosis: 3T-Based Susceptibility-Weighted Imaging Kim, Sooyoung Lee, Eun Kyoung Song, Chang June Sohn, Eunhee Diagnostics (Basel) Article This study aimed to identify the clinical significance of iron rim lesions (IRLs) in distinguishing multiple sclerosis (MS) from other central nervous system (CNS) demyelinating diseases, determine the relationship between IRLs and disease severity, and understand the long-term dynamic changes in IRLs in MS. We retrospectively evaluated 76 patients with CNS demyelinating diseases. CNS demyelinating diseases were classified into three groups: MS (n = 30), neuromyelitis optica spectrum disorder (n = 23), and other CNS demyelinating diseases (n = 23). MRI images were obtained using conventional 3T MRI including susceptibility-weighted imaging. Sixteen of 76 patients (21.1%) had IRLs. Of the 16 patients with IRLs, 14 were in the MS group (87.5%), indicating that IRLs were significantly specific for MS. In the MS group, patients with IRLs had a significantly higher number of total WMLs, experienced more frequent recurrence, and were treated more with second-line immunosuppressive agents than were patients without IRLs. In addition to IRLs, T1-blackhole lesions were observed more frequently in the MS group than in the other groups. IRLs are specific for MS and could represent a reliable imaging biomarker to improve the diagnosis of MS. Additionally, the presence of IRLs seems to reflect more severe disease progression in MS. MDPI 2023-05-26 /pmc/articles/PMC10252973/ /pubmed/37296717 http://dx.doi.org/10.3390/diagnostics13111866 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kim, Sooyoung Lee, Eun Kyoung Song, Chang June Sohn, Eunhee Iron Rim Lesions as a Specific and Prognostic Biomarker of Multiple Sclerosis: 3T-Based Susceptibility-Weighted Imaging |
title | Iron Rim Lesions as a Specific and Prognostic Biomarker of Multiple Sclerosis: 3T-Based Susceptibility-Weighted Imaging |
title_full | Iron Rim Lesions as a Specific and Prognostic Biomarker of Multiple Sclerosis: 3T-Based Susceptibility-Weighted Imaging |
title_fullStr | Iron Rim Lesions as a Specific and Prognostic Biomarker of Multiple Sclerosis: 3T-Based Susceptibility-Weighted Imaging |
title_full_unstemmed | Iron Rim Lesions as a Specific and Prognostic Biomarker of Multiple Sclerosis: 3T-Based Susceptibility-Weighted Imaging |
title_short | Iron Rim Lesions as a Specific and Prognostic Biomarker of Multiple Sclerosis: 3T-Based Susceptibility-Weighted Imaging |
title_sort | iron rim lesions as a specific and prognostic biomarker of multiple sclerosis: 3t-based susceptibility-weighted imaging |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252973/ https://www.ncbi.nlm.nih.gov/pubmed/37296717 http://dx.doi.org/10.3390/diagnostics13111866 |
work_keys_str_mv | AT kimsooyoung ironrimlesionsasaspecificandprognosticbiomarkerofmultiplesclerosis3tbasedsusceptibilityweightedimaging AT leeeunkyoung ironrimlesionsasaspecificandprognosticbiomarkerofmultiplesclerosis3tbasedsusceptibilityweightedimaging AT songchangjune ironrimlesionsasaspecificandprognosticbiomarkerofmultiplesclerosis3tbasedsusceptibilityweightedimaging AT sohneunhee ironrimlesionsasaspecificandprognosticbiomarkerofmultiplesclerosis3tbasedsusceptibilityweightedimaging |